|
PF-41949 |
REBIF NF 22 mcg (6MUI)/0.5 mL solución inyectable |
2013-11-20 |
|
Merck Serono Europe Limited |
Suiza
|
Merck |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-41950 |
REBIF NF 44 mcg (12MUI)/0.5 mL solución inyectable |
2013-11-20 |
|
Merck Serono Europe Limited |
Suiza
|
Merck |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-25149 |
Profasi 10,000 UI liofilizado y solución para uso parenteral |
2005-05-08 |
|
Laboratoires Serono S.A. |
Suiza
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-30173 |
Luveris 75 UI Liofilizado y solucion para uso parenteral |
2008-04-02 |
|
Merck Serono Europe Limited |
Uruguay
|
Resco S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31540 |
MEDIVEINE 600 mg Comprimidos |
2013-11-06 |
|
Laboratoires Des Realisations Therapeutiques Elerte |
Francia
|
Amicelco |
Colon S.A. |
Ip Cinco |
Medicite |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFH-41803 |
ANIOSYME DD1, Solución |
2013-11-05 |
|
LABORATORIES ANIOS |
Francia
|
Prohsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PFH-41804 |
STERANIOS 2%, Solución |
2013-11-05 |
|
LABORATORIES ANIOS |
Francia
|
Prohsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-57353 |
HOT LEMON RELIEF FORTE para síntomas de resfriado y gripe Polvo para solución oral |
2024-10-22 |
|
Cellchem Pharmaceutical Inc. |
Canadá
|
Comercializadora De Productos Farmacológicos |
Imcorsa |
Medicamentos Avanzados, Sociedad Anónima |
Soluciones Médicas De C.A. |
Bawell Pharma |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-50431 |
TROPISAL 20 mcg-100 mcg/pulsación Aerosol Suspensión con HFA |
2024-08-26 |
|
Agefinsa |
España
|
Iberfarma |
Agefinsa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-51079 |
AUROCRIN NASAL 50 mcg Suspensión nasal |
2024-12-04 |
|
Agefinsa |
España
|
Iberfarma |
Agefinsa (Agencia Farm. Intern., S.A.) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|